medigraphic.com
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2022, Número S1

<< Anterior Siguiente >>

Alerg Asma Inmunol Pediatr 2022; 31 (S1)


Capítulo 3. Alergia respiratoria

Rodríguez-González M, Arce-Estrada GE, Arroyo-Rojano MI, Azamar-Jácome AA, Campos-Téllez HH, Castell-Toledo MS, Cerda-Reyes S, Costa-Domínguez MC, Del Río-Navarro BE, Díaz-Mina EF, García-Chávez M, Gómez-Meza MR, González-Íñiguez KD, González-Luna RH, González-Tuyub YH, González-Uribe V, Jiménez-Chobillon A, Loredo-Mayer A, Luna-Pech JA, Nava-Ramírez CI, Navarrete-Rodríguez EM, Navarro-González PI, Ortega-Martell JA, Partida-Gaytán A, Pozo-Beltrán CF, Ramírez-Alejandri AE, Rivero-Yeverino D, Rojo-Gutiérrez MI, Sánchez-León MC, Torres-Huerta KN, Vega-Díaz TL

Idioma: Español
Referencias bibliográficas: 63
Paginas: 57-90
Archivo PDF: 957.91 Kb.


RESUMEN

Este capítulo detalla la relevancia clínica de los diferentes alergenos en escenarios clínicos de alergia respiratoria, siendo los diagnósticos de rinitis alérgica, rinoconjuntivitis alérgica y asma alérgica donde en mayor medida se ha establecido cuáles son los perfiles de sensibilización molecular pudiendo endo y fenotipificar a los pacientes con alergia respiratoria, así como establecer patrones moleculares con impacto diagnóstico, pronóstico y terapéutico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sastre J, Sastre-Ibañez M. Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol. 2016;16(6):565-570. Available in: https://doi.org/10.1097/ACI.0b013e328364f4c6

  2. Larenas-Linnemann D, Michels A, Dinger H, Shah-Hosseini K, Mosges R, Arias-Cruz A, et al. Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropics. Clin Transl Allergy. 2014; 4: 20. Available in: https://doi.org/10.1186/2045-7022-4-20

  3. Thomas WR. Hierarchy and molecular properties of house dust mite allergens. Allergol Int. 2015;64(4):304-311. Available in: https://doi.org/10.1016/j.alit.2015.05.004

  4. Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159(3):253-262. Available in: https://doi.org/10.1159/000337654

  5. Posa D, Perna S, Resch Y, Lupinek C, Panetta V, Hofmaier S, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139(2):541-549.e8. Available in: https://doi.org/10.1016/j.jaci.2016.08.014

  6. Santos da Silva E, Asam C, Lackner P, Hofer H, Wallner M, Silva Pinheiro C, et al. . Allergens of blomia tropicalis: an overview of recombinant molecules. Int Arch Allergy Immunol. 2017;172(4):203-214. Available in: https://doi.org/10.1159/000464325

  7. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonesca F. Oral mite anaphylaxis (pancake syndrome) also observed in children. Ann Allergy Asthma Immunol. 2006 May;96(5):755-756. Available in: https://doi.org/10.1016/s1081-1206(10)61079-4

  8. Campana R, Dzoro S, Mittermann I, Fedenko E, Elisyutina O, Khaitov M, Karaulov A, Valenta R. Molecular aspects of allergens in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2017;17(4):269-277. Available in: https://doi.org/10.1097/ACI.0000000000000378

  9. López-Rocha E, Rodríguez-Mireles K, Gaspar-López A, Del Rivero-Hernández L, Segura-Méndez N. Frecuencia de sensibilización a ácaros, cucaracha y camarón en adultos con alergia respiratoria. Revista Alergia México. 2014;61:59-64.

  10. Eggleston PA. Cockroach allergy and urban asthma. Journal of Allergy and Clinical Immunology. 2017;140(2):389-390.

  11. Glesner J, Filep S, Vailes LD, Wünschmann S, Chapman MD, Birrueta G, et al. Allergen content in German cockroach extracts and sensitization profiles to a new expanded set of cockroach allergens determine in vitro extract potency for IgE reactivity. J Allergy Clin Immunol. 2019;143(4):1474-1481.e8.

  12. Pomés A, Glesner J, Calatroni A, Visness CM, Wood RA, O’Connor GT, et al. Cockroach allergen component analysis of children with or without asthma and rhinitis in an inner-city birth cohort. J Allergy Clin Immunol. 2019;144(4):935-944. Available in: https://doi.org/10.1016/j.jaci.2019.05.036

  13. Oseroff C, Sidney J, Tripple V, Grey H, Wood R, Broide DH, et al. Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production. J Immunol. 2012;189(2):679-688. Available in: https://doi.org/10.4049/jimmunol.1200694

  14. Sarinho E, Sarinho FW, Sole D. Allergy to cockroaches: the need for standardization of extracts for clinical practice. Journal of Allergy and Clinical Immunology, 2014;133(2):AB241.

  15. Alvaro-Lozano M, Akdis CA, Akdis M, Alviani C, Angier E, Arasi S, et al. EAACI allergen immunotherapy user’s guide. Pediatr Allergy Immunol. 2020;31 Suppl 25(Suppl 25):1-101.

  16. Konradsen JR, Fujisawa T, van Hage M, Hedlin G, Hilger C, Kleine-Tebbe J, et al. Allergy to furry animals: New insights, diagnostic approaches, and challenges. J Allergy Clin Immunol. 2015 Mar;135(3):616-25. Available in: https://doi.org/10.1016/j.jaci.2014.08.026

  17. Schoos AM, Nwaru BI, Borres MP. Component-resolved diagnostics in pet allergy: Current perspectives and future directions. The Journal of allergy and clinical immunology, 2021;147(4):1164-1173. Available in: https://doi.org/10.1016/j.jaci.2020.12.640

  18. Patelis A, Gunnbjornsdottir M, Alving K, Borres MP, Hogman M, Janson C, Malinovschi A. Allergen extract vs. component sensitization and airway inflammation, responsiveness and new-onset respiratory disease. Clin Exp Allergy. 2016;46(5):730-740. Available in: https://doi.org/10.1111/cea.12607

  19. Matsui EC, Eggleston PA, Breysse PN, Rand CS, Diette GB. Mouse allergen-specific antibody responses in inner-city children with asthma. J Allergy Clin Immunol. 2007;119(4):910-915. Available in: https://doi.org/10.1016/j.jaci.2006.12.663

  20. Dhami S, Agarwal A. Does evidence support the use of cat allergen immunotherapy? Curr Opin Allergy Clin Immunol. 2018;18(4):350-355.

  21. Uriarte SA, Gronlund H, Wintersand A, Bronge J, Sastre J. Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study. J Investig Allergol Clin Immunol. 2022;32(2):133-140. doi: 10.18176/jiaci.0656.

  22. Shamji MH, Singh I, Layhadi JA, Ito C, Karamani A, Kouser L, et al. Passive Prophylactic Administration with a single dose of anti-Fel d 1 monoclonal antibodies REGN1908-1909 in Cat allergen-induced allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2021;204(1):23-33. doi: 10.1164/rccm.202011-4107OC.

  23. Satyaraj E, Gardner C, Filipi I, Cramer K, Sherrill S. Reduction of active Fel d1 from cats using an antiFel d1 egg IgY antibody. Immun Inflamm Dis. 2019;7(2):68-73. doi: 10.1002/iid3.244.

  24. González JPS, Hernández EB, Abellán AC, Peñalver-Mellado M. Immunogenicity of a new allergoid from Felis domesticus. Allergol Immunopathol (Madr). 2020;48(6):612-618. doi: 10.1016/j.aller.2020.02.008.

  25. Calzada D, Aranda T, M Gallego G, Escutia MR, Balsa D, Álvarez J, et al. Immunological mechanisms involved in the human response to a dog dander allergoid. Mol Immunol. 2022;145:88-96. doi: 10.1016/j.molimm.2022.02.020.

  26. Satyaraj E, Wedner HJ, Bousquet J. Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen. Allergy. 2019;74 Suppl 107(Suppl 107):5-17. Available in: https://doi.org/10.1111/all.14013

  27. González-Díaz SN, Arias-Cruz A, Ibarra-Chávez JA, Elizondo-Villarreal B, Rivero-Arias DM, Salinas-Díaz MR. Prevalencia de sensibilización a hongos en pacientes con alergia respiratoria. Rev Alerg Mex. 2016;63(2):143-53. doi: 10.29262/ram.v63i2.161.

  28. Suárez-Gutiérrez M, Macías-Garza JE, López-Ortiz DJ, Fuentes B, Álvarez-Cardona A. Sensibilización a aeroalérgenos en pacientes con rinitis alérgica en Aguascalientes, México. Rev Alerg Mex. 2019;66(4):388-393. doi: 10.29262/ram.v66i4.634.)

  29. Grinn-Gofron A, Strzelczak A. Changes in concentration of Alternaria and Cladosporium spores during summer storms. Int J Biometeorol 2013;57:759-768.

  30. Sharpe RA, Bearman N, Thornton CR, Husk K, Osborne NJ. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol. 2015;135:110-122.

  31. Kespohl S, Raulf M. Mould allergens: Where do we stand with molecular allergy diagnostics?: Part 13 of the series Molecular Allergology. Allergo J Int. 2014;23(4):120-125. Available in: https://doi.org/10.1007/s40629-014-0014-4

  32. Zukiewicz-Sobczak W, Sobczak P, Krasowska E, Zwolinski J, Chmielewska- Badora J, Galinska EM. Allergenic potential of moulds isolated from buildings. Ann Agric Environ Med. 2013;20:500-503.

  33. Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy. 2000;30:988-993.

  34. Luo W, Hu H, Wu Z, Wei N, Huang H, Zheng P, et al. Molecular allergen sensitization of Aspergillus fumigatus between allergic bronchopulmonary aspergillosis and A fumigatus-sensitized asthma in Guangzhou, Southern China. J Clin Lab Anal. 2020;34(10):e23448.

  35. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55. doi: 10.1016/j.jaci.2010.09.034.

  36. Sedghy F, Varasteh AR, Sankian M, Moghadam M. Interaction between air pollutants and pollen grains: the role on the rising trend in allergy. Rep Biochem Mol Biol. 2018;6(2):219-224.

  37. Biedermann T, Winther L, Till SJ, Panzner P, Knulst A, Valovirta E. Birch pollen allergy in Europe. Allergy. 2019;74(7):1237-1248. Available in: https://doi.org/10.1111/all.13758

  38. Palomares O, Swoboda I, Villalba M, Balic N, Spitzauer S, Rodríguez R, et al. The major allergen of olive pollen Ole e 1 is a diagnostic marker for sensitization to Oleaceae. Int Arch Allergy Immunol. 2006;141(2):110-118. Available in: https://doi.org/10.1159/000094713

  39. Barber D, de la Torre F, Feo F, Florido F, Guardia P, Moreno C, et al. Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study. Allergy. 2008;63(11):1550-8. Available in: https://doi.org/10.1111/j.1398-9995.2008.01807.x

  40. Sastre J, Sastre-Ibañez M. Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol. 2016;16(6):565-570. Available in: https://doi.org/10.1097/ACI.0000000000000318

  41. Duffort O, Palomares O, Lombardero M, Villalba M, Barber D, Rodríguez R, Polo F. Variability of Ole e 9 allergen in olive pollen extracts: relevance of minor allergens in immunotherapy treatments. Int Arch Allergy Immunol. 2006;140(2):131-138. Available in: https://doi.org/10.1159/000092532

  42. Huang X, Tsilochristou O, Perna S, Hofmaier S, Cappella A, Bauer CP, et al. Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life. Allergy. 2018;73(2):421-430. Available in: https://doi.org/10.1111/all.13269

  43. Fernández-González M, Álvarez-López S, González-Fernández E, Jesús Aira M, Rodríguez-Rajo FJ. Cross-reactivity between the Betulaceae family and fallout in the real atmospheric aeroallergen load. Sci Total Environ. 2020;715:136861. Available in: https://doi.org/10.1016/j.scitotenv.2020.136861

  44. Hayek B, Vangelista L, Pastore A, Sperr WR, Valent P, Vrtala S, et al. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition. J Immunol. 1998;161(12):7031-7039.

  45. Hemmer W, Focke M, Wantke F, Gotz M, Jarisch R, Jäger S, Götz M. Ash (Fraxinus excelsior)-pollen allergy in central Europe: specific role of pollen panallergens and the major allergen of ash pollen, Fra e 1. Allergy. 2000;55(10):923-930. Available in: https://doi.org/10.1034/j.1398-9995.2000.00671.x

  46. Subiza J, Jerez M, Jiménez JA, Narganes MJ, Cabrera M, Varela S, et al. Allergenic pollen pollinosis in Madrid. J Allergy Clin Immunol. 1995;96(1):15-23. Available in: https://doi.org/10.1016/s0091-6749(95)70028-5

  47. Barderas R, Purohit A, Papanikolaou I, Rodríguez R, Pauli G, Villalba M. Cloning, expression, and clinical significance of the major allergen from ash pollen, Fra e 1. J Allergy Clin Immunol. 2005;115(2):351-357. Available in: https://doi.org/10.1016/j.jaci.2004.10.001

  48. Asturias JA, Ibarrola I, Fernández J, Arilla MC, González-Rioja R, Martínez A. Pho d 2, a major allergen from date palm pollen, is a profilin: cloning, sequencing, and immunoglobulin E cross-reactivity with other profilins. Clin Exp Allergy. 2005;35(3):374-381. Available in: https://doi.org/10.1111/j.1365-2222.2005.02179.x

  49. Huertas AAJ, Mozota BJM, Garcia-Cervantes AM. Prevalencia de sensibilización cutánea a polen de palmera y de morera en el sureste español. Alergol Inmunol Clin. 2002;17:193-196.

  50. Calzada D, Cremades-Jimeno L, López-Ramos M, Cárdaba B. Peptide allergen immunotherapy: a new perspective in olive-pollen allergy. Pharmaceutics. 2021;13(7):1007. Available in: https://doi.org/10.3390/pharmaceutics13071007

  51. Atanasio A, Franklin MC, Kamat V, Hernandez AR, Badithe A, Ben LH, et al. Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response. The Journal of Allergy and Clinical Immunology. 2021;149(1):200-211. Available in: https://doi.org/10.1016/j.jaci.2021.05.038

  52. Study to assess the efficacy of anti-bet v 1 monoclonal antibodies in adults to reduce symptoms of seasonal allergic rhinitis. Available in: https://clinicaltrials.gov/ct2/show/NCT04709575

  53. Mendy A, Zeldin DC. Phl p 4: an early indicator of grass pollen allergy? J Allergy Clin Immunol. 2020;145(6):1556-1557. doi: 10.1016/j.jaci.2020.04.011.

  54. Kailaivasan T, Davies JM. The molecular allergology of subtropical grass pollen. Mol Immunol. 2018;100:126-135. Available in: https://doi.org/10.1016/j.molimm.2018.03.012

  55. Westman M, Aberg K, Apostolovic D, Lupinek C, Gattinger P, Mittermann I, et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J Allergy Clin Immunol. 2020;145(4):1174-1181.e6. Available in: https://doi.org/10.1016/j.jaci.2020.01.006

  56. Tripodi S, Frediani T, Lucarelli S, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol. 2012;129:834-839; e8.

  57. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol. 2002;2:446-453.

  58. Popescu FD. Molecular biomarkers for grass pollen immunotherapy. World J Methodol. 2014;4(1):26-45. doi: 10.5662/wjm.v4.i1.26.

  59. Pablos I, Wildner S, Asam C, Wallner M, Gadermaier G. Pollen allergens for molecular diagnosis. Curr Allergy Asthma Rep. 2016;16(4):31. doi: 10.1007/s11882-016-0603-z.

  60. Scaparrotta A, Verini M, Consilvio NP, Cingolani A, Rapino D, Attanasi M, et al. Sensitization to timothy grass pollen allergenic molecules in children. Multidiscip Respir Med. 2013;8(1):17. doi: 10.1186/2049-6958-8-17.

  61. Gadermaier G, Dedic A, Obermeyer G, Frank S, Himly M, Ferreira F. Biology of weed pollen allergens. Curr Allergy Asthma Rep. 2004;4(5):391-400.

  62. Ambrosia trifida (giant ragweed). Available in: https://www.cabi.org/isc/datasheet/4693

  63. Stemeseder T, Hemmer W, Hawranek T, Gadermaier G. Marker allergens of weed pollen - basic considerations and diagnostic benefits in the clinical routine: part 16 of the series molecular allergology. Allergo J Int. 2014;23(8):274-280. Available in: https://doi.org/10.1007/s40629-014-0033-1




2020     |     www.medigraphic.com